Amedeo's Top 20

Amedeo Smart

Independent Medical Education

24 July 2023

Multidisciplinary Journal Club

  1. Stambler BS, Camm AJ, Alings M, Dorian P, et al.
    Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial.
    Lancet 2023;402:118-128.

  1. Parry EM, Ten Hacken E, Wu CJ.
    Richter syndrome: novel insights into the biology of transformation.
    Blood 2023;142:11-22.

  2. Hazra A, Landovitz RJ, Marzinke MA, Quinby C, et al.
    Breakthrough HIV-1 infection in setting of cabotegravir for HIV pre-exposure prophylaxis.
    AIDS 2023.

  3. Van de Werf F, Ristic AD, Averkov OV, AriasMendoza A, et al.
    Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction in STREAM-2: A Randomized, Open-Label Trial.
    Circulation 2023.

  4. Zhu Z, Rosenkranz KA, Kusunoki Y, Li C, et al.
    Finerenone Added to RAS/SGLT2 Blockade for Chronic Kidney Disease in Alport Syndrome. Results of a Randomized Controlled Trial with Col4a3-/- Mice.
    J Am Soc Nephrol 2023.

  1. Reddy KR, McLerran D, Marsh T, Parikh N, et al.
    Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: the Multi-center Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study.
    Gastroenterology 2023.

  2. Owen DH, Singh N, Ismaila N, Masters G, et al.
    Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.2.
    J Clin Oncol 2023.

  3. Wilde H, Tomlinson C, Mateen BA, Selby D, et al.
    Hospital admissions linked to SARS-CoV-2 infection in children and adolescents: cohort study of 3.2 million first ascertained infections in England.
    BMJ 2023;382:e073639.

  4. Sellier P, Alexandre-Castor G, Brun A, Hamet G, et al.
    Updated mortality and causes of death in 2020-2021 in people living with HIV: a multicenter study in France.
    AIDS 2023.

  5. Barnes E, Goodyear CS, Willicombe M, Gaskell C, et al.
    SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
    Nat Med 2023.

  1. Shikuma CM, Wojna V, De Gruttola V, Siriwardhana C, et al.
    Impact of ART intensification with CCR5 antagonist maraviroc on HIV-associated neurocognitive impairment.
    AIDS 2023.

  2. Verburgh ML, Wit FWNM, Boyd A, Reiss P, et al.
    No evidence of rapid reversibility of tenofovir alafenamide and/or integrase strand transfer inhibitor-associated weight gain.
    AIDS 2023.

  3. Litton JK, Regan MM, Pusztai L, Rugo HS, et al.
    Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP.
    J Clin Oncol 2023.

  4. Nissen SE, Menon V, Nicholls SJ, Brennan D, et al.
    Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients.
    JAMA 2023.

  5. Jung MK, Lee SY, Min EJ, Ko JM, et al.
    CT Differences of Pulmonary Tuberculosis According to Presence of Pleural Effusion.
    Chest 2023.

  1. Park TY, Jeon J, Lee N, Kim J, et al.
    Co-transplantation of autologous T(reg) cells in a cell therapy for Parkinson's disease.
    Nature 2023.

  2. Kotsopoulos J, Gronwald J, Huzarski T, Aeilts A, et al.
    Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
    Breast Cancer Res Treat 2023.

  3. Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, et al.
    The 2023 Bethesda System for Reporting Thyroid Cytopathology.
    Thyroid 2023.

  4. Angel JB, Freilich J, Arthurs E, Ban JK, et al.
    Adherence to oral antiretroviral therapy in Canada, 2010-2020: A retrospective analysis of claims data.
    AIDS 2023.

  5. Jester DJ, Kohn JN, Tibirica L, Thomas ML, et al.
    Differences in Social Determinants of Health Underlie Racial/Ethnic Disparities in Psychological Health and Well-Being: Study of 11,143 Older Adults.
    Am J Psychiatry 2023;180:483-494.


more..

Privacy Policy